Female Genital Tract- Cervix Flashcards

(72 cards)

1
Q

The ______________is both a sentinel for potentially serious upper genital tract infections and a target for
viruses and other carcinogens, which may lead to invasive carcinoma.

A

CERVIX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Worldwide, cervical
carcinoma is the_________________r in women, with an estimated 493,000 new cases
each year, over half of which are fatal. In the United States, 11,150 women were diagnosed with
cervical cancer and 3670 women died from this disease in 2007.

A

second most common cance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The potential threat of cancer
is central to ______________ and histologic interpretation of
________________specimens by the pathologist.

A

Papanicolaou (Pap) smear screening programs

biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inflammations

A

ACUTE AND CHRONIC CERVICITIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the
cervical and vaginal squamous mucosa and formation of intracellular glycogen vacuoles in the
squamous cells.

As these cells are shed, the glycogen provides a substrate for endogenous
vaginal aerobes and anaerobes, including streptococci, enterococci, Escherichia coli, and
staphylococci; however, the normal vaginal and cervical flora is largely dominated by
__________________

Lactobacilli produce lactic acid that maintains the vaginal pH below 4.5, suppressing
the growth of other saprophytic and pathogenic organisms. In addition, at low pH, lactobacilli
produce bacteriotoxic hydrogen peroxide (H2O2). [21] At higher, more alkaline pH caused by
bleeding, sexual intercourse, vaginal douching as well as during antibiotic treatment, lactobacilli
decrease H2O2 production, permitting the overgrowth of other microorganisms, which may
result in clinically apparent cervicitis or vaginitis. Some degree of cervical inflammation may be
found in virtually all women,
and it is usually oflittle clinical consequence.However,infections by
gonococci, chlamydiae, mycoplasmas, and herpes simplex virus may produce significant acute
or chronic cervicitis
and are important to identify due to their association with upper genital tract
disease, complications during pregnancy, and sexual transmission.

Marked cervical
inflammation produces reparative and reactive changes of the epithelium and shedding of
atypical-appearing squamous cells,
and therefore may cause a nonspecific,abnormal Pap test
result.

A

lactobacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

_______________ are benign exophytic growths that occur in 2% to 5% of adult women.

A

Endocervical polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Perhaps the major significance of polyps lies in their production of______________ that arouses suspicion of some more ominous lesion.

A

irregular vaginal “spotting” or
bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most polyps arise within the
_______________ and vary from small and sessile to large, 5-cm masses that may protrude
through the cervical os.

A

endocervical canal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

All polyps are __________________________________often
accompanied by inflammation ( Fig. 22-14 ). Simple curettage or surgical excision effects a
cure.

A

soft, almost mucoid, lesions composed of a loose
fibromyxomatous stroma harboring dilated, mucus-secreting endocervical glands,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endocervical polyp composed of ________________________

A

a dense fibrous stroma covered with
endocervical columnar epithelium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Premalignant and Malignant

The pathogenesis of cervical carcinoma has been delineated by a series of epidemiologic,
clinicopathologic, and molecular genetic studies.

Epidemiologic data have long implicated a
sexually transmitted agent, which is now established to be _________.

A

HPV.

Note : For his discovery of HPV as a
cause of cervical cancer, Harald zur Hausen was awarded the Nobel Prize in 2008. HPVs are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HPVs are DNA viruses that are typed based on their DNA sequence and subgrouped into ______________ and __________

A
  1. high and
  2. low

oncogenic risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

___________ are currently considered to be the single most
important factor
incervical oncogenesis.

A

High oncogenic risk HPVs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

High oncogenic risk HPVs have also been detected in
________________________________as detailed in Chapter 7 .

A

vaginal squamous cell carcinomas and in a subset of vulvar, penile, anal, tonsillar, and other
oropharyngeal carcinomas,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

As noted earlier,__________________
are the cause of the sexually transmitted vulvar, perineal, and perianal condyloma acuminatum.

A

low oncogenic risk HPVs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

There are 15 high oncogenic risk HPVs that are currently identified. From the point of view of
cervical pathology,_________________ are the most important.

A

HPV 16 and HPV 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

___________________alone accounts for
almost 60% of cervical cancer cases, and _____________ accounts for another 10% of cases;
other
HPV types contribute to less than 5% of cases, individually.

A

HPV 16

HPV 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

[22] The risk factors for cervical
cancer are related to both host and viral characteristics such as HPV exposure, viral
oncogenicity, i
nefficiency of immune response, and presence of co-carcinogens. [23] These
include:

A
  1. Multiple sexual partners
  2. A male partner with multiple previous or current sexual partners
    * *3. Young age at first intercourse**
    * *4. High parity**
  3. Persistent infection with a high oncogenic risk HPV, e.g., HPV 16 or HPV18
  4. Immunosuppression
  5. Certain HLA subtypes
    * *8. Use of oral contraceptives**
  6. Use of nicotine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Genital HPV infections are extremely common; most of them are asymptomatic, do not cause
any tissue changes, and therefore are not detected on Pap test
. Figure 22-15 shows agedependent
prevalence of HPVs in cervical smears in women with normal Pap test results.

The
high peak of HPV prevalence in 20-year-olds is related to sexual début, while the subsequent
decrease in prevalence reflects acquisition of immunity and monogamous relationships.

Most
HPV infections are transient and are eliminated by the immune response in the course of months. On average, 50% of HPV infections are cleared within 8 months, and 90% of infections
are cleared within 2 years. The duration of the infection is related to HPV type; on average,
infections with high oncogenic risk HPVs last longer than infections with low oncogenic risk
HPVs, 13 months versus 8 months, respectively. [24] Persistent infection increases the risk of
the development of cervical precancer and subsequent carcinoma.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HPVs infect ___________________ in areas of epithelial breaks, or
_______________ ( Fig. 22-16 ).
HPVs cannot infect the mature superficial squamous cells that cover the ectocervix, vagina, or
vulva.

Establishing HPV infection in these sites requires damage to the surface epithelium,
which gives the virus access to the immature cells in the basal layer of the epithelium.

A

immature basal cells of the squamous epithelium

immature metaplastic squamous cells present at the squamocolumnar junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The
cervix, with its relatively large areas of immature squamous metaplastic epithelium, is
particularly vulnerable to HPV infection as compared, for example, with vulvar skin and mucosa
that are covered by mature squamous cells.

This difference in epithelial susceptibility to HPV
infection accounts for the marked difference in incidence of HPV-related cancers arising in
different sites, and explains the high frequency of cervical cancer in women or anal cancer in
homosexual men and a relatively low frequency of vulvar and penile cancer.

A

thats why! :)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Although the virus can infect only the immature squamous cells, replication of HPV occurs in the
maturing squamous cells and results in a cytopathic effect,
_________________,” consisting of
nuclear atypia and a cytoplasmic perinuclear halo.

To replicate, HPV has to induce DNA
synthesis in the host cells. Since HPV replicates in maturing, nonproliferating squamous cells, it
must reactivate the mitotic cycle in such cells.

Experimental studies have shown that HPV
activates the cell cycle by interfering with the function of Rb and p53, two important tumor
suppressor genes

A

“koilocytic atypia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

_______________ proteins are critical for the oncogenic effects of HPV.

They can promote cell
cycle by binding to RB
andup-regulation of cyclin E (E7); interrupt cell death pathways by
binding to p53 (E6); induce centrosome duplication and genomic instability (E6, E7); and
prevent replicative senescence by up-regulation of telomerase (E6) ( Chapter 7 ).

A

Viral E6 and E7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

________________
induces rapid degradation of p53 via ubiquitin-dependent proteolysis, reducing p53 levels by
two- to three-fold.

E7 complexes with the hypophosphorylated (active) form of RB, promoting its
proteolysis via the proteosome pathway. Because hypophosphorylated RB normally inhibits Sphase
entry via binding to the E2F transcription factor, the two viral oncogenes cooperate to
promote DNA synthesis while interrupting p53-mediated growth arrest and apoptosis of
genetically altered cells. Thus, the viral oncogenes are critical in extending the life span of
epithelial cells—a necessary component of tumor development.

A

HPV E6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The **physical state** of the virus differs in different lesions, being integrated into the host DNA in cancers, and present as free (episomal) viral DNA in condylomata and most precancerous lesions. Certain chromosome abnormalities, including **deletions at 3p and amplifications of 3q,** have been **associated with cancers containing specific (HPV-16) papillomaviruses.** Even though HPV has been firmly established as a causative factor for cancer of the cervix, **the evidence does not implicate HPV as the only factor. A high percentage of young women are** infected with **one or more HPV types** during their **reproductive years, and only a few develop cancer.** Other cocarcinogens, the immune status of the individual, and hormonal and other factors influence whether the HPV infection will regress or persist and eventually progress to cancer. [23]
26
In addition to infecting squamous cells, HPVs may also infect \_\_\_\_\_\_\_\_\_\_\_\_\_present in the cervical mucosa and cause malignant transformation, resulting in adenocarcinomas, and adenosquamous and neuroendocrine carcinomas; these tumor subtypes, however, are less common since glandular and neuroendocrine cells do not support effective HPV replication.
glandular cells or neuroendocrine cells
27
The classification of cervical precancerous lesions has evolved over time and the terms from the different classification systems are currently used interchangeably.
CERVICAL INTRAEPITHELIAL NEOPLASIA Note : Hence a brief review of the terminology is warranted. The oldest classification system classified lesions as having** mild dysplasia** on one end and **severe dysplasia/carcinoma in situ on the other**. This was followed by **cervical intraepithelial neoplasia (CIN) classification**, **with mild dysplasia termed CIN I**,** moderate dysplasia CIN II,** and **severe dysplasia termed CIN III.** Because the decision with regard to patient management is two-tiered (observation versus surgical treatment), the three-tier classification system has been **recently simplified to a two-tiered system**, with** CIN I renamed low-grade squamous intraepithelial lesion (LSIL)** and** CIN II and CIN III** combined into one category referred to as **high-grade squamous intraepithelial lesion (HSIL)**
28
CIN I renamed \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
low-grade squamous intraepithelial lesion (LSIL)
29
CIN II and CIN III combined into one category referred to as\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
high-grade squamous intraepithelial lesion (HSIL)
30
Mild dysplasia CIN I
Low-grade SIL (LSIL)
31
Moderate dysplasia \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ High-grade SIL (HSIL)
CIN II
32
* *Severe dysplasia** CIN III High-grade SIL (HSIL) * *Carcinoma in situ** CIN III High-grade SIL (HSIL)
33
* \_\_\_\_\_\_\_\_\_\_\_\_\_\_are associated with **productive HPV infection**, but show **no significant disruption or** **alteration of the host cell cycle**. * **Most regress spontaneously**, with only a **small percentage** **progressing to HSIL**. * ** does not progress directly to invasive carcinoma.** For these reasons * ** is not treated like a premalignant lesion**.
LSILs
34
In \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_, there is a **progressive deregulation** of the **cell cycle by HPV**, which results in **increased cellular proliferation, decreased or arrested** **epithelial maturation**, and a **lower rate of viral replication**, as compared with LSIL. HSILs are one tenth as common as LSILs.
HSIL
35
The **diagnosis of SIL** is based on identification of \_\_\_\_\_\_\_\_\_\_\_\_-characterized by **nuclear enlargement, hyperchromasia (dark staining**), presence of **coarse chromatin granules**, and **variation of nuclear sizes and shapes.** The nuclear changes may be accompanied by **cytoplasmic halo**s indicating **disruption of the cytoskeleton before release of the virus** into the environment.
nuclear atypia
36
**Nuclear alterations** and **perinuclear halo** are termed\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
koilocytic atypia
37
. The grading of SIL into **low or high grade** is **based** on expansion of the \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_-
immature cell layer from its normal, basal location.
38
If the **atypical, immature squamous cells** are **confined** to the **lower one third of the epithelium**, the lesion is graded as\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_;
LSIL
39
If the atypical, immature squamous cells are confined to the expand to two thirds of the epithelial thickness, it is graded as \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
HSIL.
40
More than **80% of LSILs** and **100% of HSILs** are associated with\_\_\_\_\_\_\_\_\_\_\_\_ HPVs.'
high oncogenic risk
41
More than **80% of LSILs** and **100% of HSI**Ls are associated with high oncogenic risk HPVs. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_is the **single most common HPV type detected in both categories of lesions**.
HPV 16
42
Table 22-2 shows rates of regression and progression of SILs within 2-year follow-up. [25] Although the majority of HSILs develop from LSILs, approximately **20% of cases of HSIL** develop \_\_\_\_\_\_\_\_\_\_\_\_\_\_. [26] The rates of progression are by no means uniform, and although HPV type—especially HPV 16—is associated with increased risk, it is difficult to predict the outcome in an individual patient. These findings underscore that the risk of developing precancer and cancer is conferred only in part by HPV type, **and depends also on immune status and environmental factors.** Progression to invasive carcinoma, when it occurs, may take place in a few months to more than a decade
de novo, without the preexisting LSIL
43
Lesion Regress Persist Progress LSIL 60% 30% 10% to HSIL HSIL 30% 60% 10% to carcinoma
44
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ is the **most common histologic subtype** of c**ervical cance**r, accounting for approximately **80% of cases**.
Squamous cell carcinoma
45
As outlined above, **\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** is an **immediate precursor** of **cervical squamous cell carcinoma**.
** HSIL**
46
The **second most common tumo**r type is **\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** which constitutes about **15%** of **cervical cancer cases** and develops from a **precursor lesion called adenocarcinoma in situ**.
**cervical adenocarcinoma,**
47
The second most common tumor type is cervical **adenocarcinoma,** which constitutes about **15% of cervical cance**r cases and develops from a **precursor lesion** called\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
adenocarcinoma in situ.
48
**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** are rare cervical tumors that account for the **remaining 5% of cases**. All of the above tumor types are caused by **high oncogenic risk HPVs**. The **clinical characteristics and risk factors are the same for each tumor type,**with the**exception that adenocarcinomas and adenosquamous and neuroendocrine carcinomas t**ypically present with**advanced-stage disease**. This unfortunate outcome occurs because Pap screening is less effective in detecting these cancers. Patients with **adenosquamous and neuroendocrine carcinomas,** therefore, have a **less favorable prognosi**s than patients with squamous cell carcinomas or adenocarcinomas.
** Adenosquamous and neuroendocrine carcinomas**
49
The peak incidence of invasive cervical carcinoma is**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_.** With the advent of widespread screening, many cervical carcinomas ar**e detected at a subclinical stage, during evaluation of an abnormal** **Pap smear.**
** 45 years**
50
**Invasive cervical carcinoma** may manifest as **either\_\_\_\_\_\_\_\_\_\_\_\_\_\_ or \_\_\_\_\_\_\_\_\_\_\_\_\_.**
* * fungating (exophytic) or** * *infiltrative cancers.**
51
On histologic examination, squamous cell carcinomas are composed of **nests and tongues** of **malignant squamous epithelium**, either **keratinizing or nonkeratinizing,\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_**( Fig. 22-19 ).
** invading the underlying cervical stroma**
52
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ are characterized by **proliferation of glandular epithelium**composed of**malignant endocervical cells with large, hyperchromatic nuclei**and**relatively mucin-depleted cytoplasm,**resulting in**dark appearance of the glands,** as compared with the normal endocervical epithelium ( Fig. 22-20A )
Adenocarcinomas
53
carcinomas are tumors composed of **intermixed malignant glandular** and **malignant squamous epithelium.**
. Adenosquamous
54
**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** typically have an appearance similar to **small-cell carcinoma of the lun**g (see Chapter 15 ); however, in contrast to the lung tumor, which is not related to HPV infection, **cervical small-cell carcinomas are positive for high oncogenic risk HPVs.**
**Neuroendocrine cervical carcinomas**
55
Advanced cervical carcinoma extends by **direct spread to involve contiguous tissues,** including the **paracervical tissues, urinary bladder, ureters, rectum, and vagina.** Local and distant lymph nodes are also involved. Distant metastases may be found in the liver, lungs, bone marrow, and other structures.
56
Cervical cancer is staged as follows: Stage 0.
Carcinoma in situ (CIN III, HSIL)
57
Stage I.
Carcinoma confined to the cervix
58
Ia.
Preclinical carcinoma, that is, diagnosed **only by microscopy**
59
Ia1. (see Fig. 22-19A
Stromal invasion no deeper than 3 mm and no wider than 7 mm (so-called microinvasive carcinoma
60
Ia2.
Maximum depth of invasion of stroma deeper than 3 mm and no deeper than 5 mm taken from base of epithelium; horizontal invasion not more than 7 mm
61
Ib.
Histologically invasive carcinoma confined to the cervix and greater than stage Ia2
62
Stage II.
Carcinoma extends beyond the cervix but not to the pelvic wall. Carcinoma involves the vagina but not the lower third.
63
Stage III.
Carcinoma has extended to the pelvic wall. On rectal examination there is **no cancer-free** **space between the tumor and the pelvic wall.** The tumor involves the lower third of the vagina.
64
Stage IV
Carcinoma has extended beyond the true pelvis or has involved the mucosa of the bladder or rectum. This stage also includes cancers with metastatic dissemination.
65
Clinical Features. **More than half of invasive cervical cancers** are detected in women **who did not participate in regular screening.** While early invasive cancers of the cervix (microinvasive carcinomas) may **be treated by cone biopsy alon**e, **most invasive cancers are managed** by\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_and, for advanced lesions, irradiation.
hysterectomy with lymph node dissection
66
The prognosis and survival for invasive carcinomas **depend largely on the stage at which cancer is first discovered and to some degree on the cell type**, with**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_**tumors having a**very poor prognosis.**
** small-cell neuroendocrine**
67
​With current methods of treatment there is a **5-year survival rate of at least 95% for stage Ia** (including microinvasive) carcinomas,
68
about 80% to 90% with stage Ib, 75% with stage II, and less than 50% for stage III and higher. Most patients with stage IV cancer die as a consequence of local extension of the tumor (e.g., into and about the urinary bladder and
69
Cervical Cancer Screening and Prevention Cervical cancer prevention and control can be divided into several components.
1. One includes **cytologic screening** and management of **Pap smear abnormalities**. 2. Another is the **histologic diagnosis and removal of precancerous lesions.** 3. Still another component is **surgical removal of invasive cancers**, with adjunctive **radiation therapy and chemotherapy.** 4. A new aspect is an **HPV vaccination program**, approved by the US Food and Drug Administration (FDA) for preventing HPV infection. HPV vaccines are also being evaluated for effectiveness as a therapeutic tool in cervical precancers.
70
The **reason that cytologic screening** is so effective in **preventing cervical cancer** is that the \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ . This lesion may **exist in the noninvasive stage for years**and**shed abnormal cells that can be detected on cytologic** examination. Pap tests are cytologic preparations of exfoliated cells from the cervical transformation zone that are stained with the **Papanicolaou method**. Using a **spatula or brush,** the transformation zone of the cervix is circumferentially **scraped and the cells are smeared or** **spun down onto a slide.** Following fixation and staining, the cytotechnologist, a person specifically trained to identify cytologic abnormalities, screens the smears. The cellular changes on Pap test illustrating the spectrum from normal, through LSIL to HSIL, are shown in Figure 22- 21 .
majority of cancers are preceded by a long-standing precancerous lesion
71
The **false-negative error rate** of the Pap test is around **10% to 20%.** Most of these falsenegative tests stem from sampling errors. Recommendations for the frequency of Pap screening vary, but in **general the first smear should be at age \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** and **thereafter on an annual basis.** **After age 30**, women **who have had three consecutive normal cytology**results may be screened every**2 to 3 years.**
21 years or within 3 years of onset of sexual activity,
72